SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : IMGX, currently $3.50
IMGX 0.00010000.0%Oct 28 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jay Morrison who wrote (500)11/12/1997 7:36:00 AM
From: Constance K. Landis  Read Replies (1) of 665
 
Constance mumbled:
<<How can you possibly even consider comparing IMGX to these other stocks?>>

Because IMGX is a stock that is very similar to those stocks. You should re-read
everything written previously so that you better understand the details. Your entire post
demonstrates that you do not.

Similar, yes they are both software companies, yes they have similar market caps. As for accelerated share value and profitability, clearly there is little to compare.

<<No analyst worth a damn is going to promote this stock or for that matter any stock
that perpetuates continued losses.>>

That is not true. I have seen many companies perpetuate losses and be covered. Apple
comes to mind.

What a grand example. I only wish that IMGX will have as many profitable 1/4's. Apple remains "covered" due to their continued impact on personal computing and due to their historical growth. You seem obsessed to compare "apples(no pun intended) to lemons".

<<Even mentioning it in the same vein with Microsoft is absolutely ridiculous. Come
back to reality.>>

Once again, you missed the point of WHY it was mentioned. MSFT and the others
were mentioned to demonstrate that software companies can trade anywhere between
5x sales to as high as 10x sales. MSFT is currently 10x sales. FILE is currently 5.8x
sales, but has been as high as 10x sales. There is nothing that is special about how
Microsoft is judged. It is priced exactly the same as other software companies. By p/e
and by revenue. They are simply the biggest. Using MSFT as an example is logical
assuming that IMGX is a growth story.

Missed the point, indeed. You were the one who stated "But this is all wishful thinking on my part". Again, your assumption that IMGX is "a growth story" is unsupported by real data.

You failed to understand the basic concept that domestic (non-Dorotech) sales are
growing and growing quite well. Dorotech will be gone by next month in my opinion.
Q4 results will likely be stated in terms of IMGX only without Dorotech. US revenue
last quarter was $6.5 million. It will at least be $7.4 million next quarter (Zannett target)
and is likely to be around $8 million. That is a growth company that deserves to be
rated as other software growth companies.

What else does your crystal ball tell you? You continue to project based on assumptions. What makes you think they will unload Dorotech next month? An attempt to improve year end numbers? What new excuses for failed performance will they use without Dorotech?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext